Effects of Moderate-Dose Treatment With Varenicline on Neurobiological and Cognitive Biomarkers in Smokers and Nonsmokers With Schizophrenia or Schizoaffective Disorder
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.